Isabella Visuri

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Ejection Fraction

Patient Reported Outcomes

Ulcerative Colitis

Top Venues

Scandinavian journal of gastroenterology

Alimentary pharmacology & therapeutics

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. Therapeutic advances in gastroenterology 16 (2023)
Joel Thunberg, Olle Grännö, Daniel Bergemalm, Carl Eriksson, Isabella Visuri, Michael Eberhardson, Jonas Halfvarson
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels. Scandinavian journal of gastroenterology (2023)
Carl Eriksson, Isabella Visuri, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Daniel Bergemalm, null null, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid, Jonas Halfvarson
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. Scandinavian journal of gastroenterology 56 (11) (2021)
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, Jonas F Ludvigsson, Jonas Halfvarson
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' reply. Alimentary pharmacology & therapeutics 54 (6) (2021)
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, null null, Jonas F Ludvigsson, Jonas Halfvarson
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register. Alimentary pharmacology & therapeutics 54 (7) (2021)